webinar register page

Webinar banner
COVID-19 & Lung Cancer - Changing Care Worldwide
Featured Panelists:

- Gilberto De Lima Lopes, MD, MBA, FAMS, University of Miami
- Rajesh Shah, MD, VA Palo Alto Health Care System and Stanford University
- Chee-Keong Toh, MBBS, MRCP, FAMS, Curie Oncology

Moderator: Min-Han Tan, MBBS, FRCP, PhD, Lucence Diagnostics

The COVID-19 pandemic has adversely affected the care of cancer patients everywhere through disruptions of healthcare delivery.

Learn more about how oncology leaders are adapting their practice and responding to new challenges in diagnosis, treatment, and monitoring of lung cancer worldwide. We’re bringing together global leaders in academic medicine and clinical practice to offer their perspective and insights.

This webinar organized by the Singapore Society of Oncology will cover:
- Clinical impact of COVID-19 on imaging and diagnosis
- Considerations of treatment selection for lung cancer patients
- A case study of a ventilated patient initially suspected of COVID-19, and subsequently diagnosed with lung cancer profiled by liquid biopsy technology

Jun 4, 2020 05:00 PM in Pacific Time (US and Canada)

Webinar logo
* Required information


Professor Gilberto De Lima Lopes
Professor De Lima Lopes is the Medical Director for International Programs and Associate Director for Global Oncology at the Sylvester Comprehensive Cancer Center and Associate Professor at the University of Miami Miller School of Medicine. He is an associate editor for ASCO University and for ASCO’s Journal of Global Oncology. He has published widely, with more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, The Lancet, The Lancet Oncology, and Nature Reviews, and has lectured nationally and internationally. He has been principal or co-principal investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary, and thoracic cancers. He is a steering committee member of the COVID-19 and Cancer Consortium (CCC19), a consortium of over 100 cancer centers and other organizations who have come together to collect data about cancer patients who have been infected with COVID-19.
Dr. Rajesh Shah
Dr. Rajesh Shah is the Director of Interventional Radiology, Associate Chief of Radiology at the VA Palo Alto Health Care System, and Clinical Associate Professor, Radiology at Stanford University. He is an interventional radiologist with a particular interest in interventional oncology. He performs a wide range of procedures including ablations of the lung, liver, kidney, and bone, chemoembolization, bland embolization, and radioembolization of tumors, biopsies, drainages, and interventions on both venous and arterial sides. He was the first physician to perform SIR-spheres radioembolization for metastatic tumors to the liver within the VA hospital system. He is the primary investigator on several clinical trials related to liver cancer. He has performed research on improving lung cancer biopsy yields, and has a significant clinical practice in lung cancer. He is involved in research on the application of machine learning/AI and radiomics/radiogenomics to lung cancer identification.
Dr. Chee-Keong Toh
Dr Chee-Keong Toh is a medical oncologist at Curie Oncology subspecializing in lung cancer. He previously led the Lung Cancer Consortium project at the National Cancer Centre Singapore to coordinate lung cancer research in Singapore, paving the way for publications in Nature genetics 2020; Nature 2018; Nature Comms 2019; etc. Dr Toh was the first investigator to establish the never-smoking, female-predominant lung adenocarcinoma patients as a distinct clinical entity (J Clin Onc, 2004).